The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type ocular replication and eye disease

Journal of Infectious Diseases

Volumn 179, Issue 5, 1999, Pages 1086-1093

  Ghiasi, Homayon ^a   Steve, Cai ^a   Slanina, Susan M ^a   Perng, Guey Chuen ^a   Nesburn, Anthony B ^a   Wechsler, Steven L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 4;

ADOLESCENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BLEPHARITIS; CONTROLLED STUDY; CORNEA INJURY; EYE DISEASE; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; IMMUNE RESPONSE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; EYE; HERPESVIRUS 1, HUMAN; INTERLEUKIN-2; INTERLEUKIN-4; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; VACCINATION; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0033006718     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314736     Document Type: Article

References (41)

1. 1. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76: 241-51.
2. 2. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990;172:921-9.
3. + T cells. Annu Rev Immunol 1994;12:635-73.
4. 4. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
5. 5. Hsieh CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci USA 1992;89:6065-9.
6. 6. Abehsira-Amar O, Gibert M, Joliy M, Theze J, Jankovic DL. IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells. J Immunol 1992;148:3820-9.
7. 7. Finkelman FD, Katona IM, Urban JF Jr, et al. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988;141:2335-41.
8. 8. Finkelman FD, Holmes J, Katona IM, et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990;8:303-33.
9. 9. Finkelman FD, Katona IM, Urban JF Jr, Paul WE. Control of in vivo IgE production in the mouse by interleukin 4. Ciba Found Symp 1989;147: 3-17.
10. 10. Biron CA, Young HA, Kasaian MT. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J Exp Med 1990;171:173-88.
11. 11. Nossal GJ. Cellular mechanisms of immunologic tolerance. Annu Rev Immunol 1983;1:33-62.
12. 12. Ghiasi H, Bahri S, Nesburn AB, Wechsler SL. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest Ophthalmol Vis Sci 1995;36:1352-60.
13. 13. Ghiasi H, Wechsler SL, Kaiwar R, Nesburn AB, Hofman FM. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J Virol 1995;69:334-40.
14. 14. Ghiasi H, Roopenian DC, Slanina S, Cai S, Nesburn AB, Wechsler SL. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge. Immunology 1997;91:430-5.
15. 15. Biron CA. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 1994;6:530-8.
16. 16. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. T. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
17. 17. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I. Immune responses in interleukin-2-deficient mice. Science 1993;262:1059-61.
18. 18. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-8.
19. 19. Ghiasi H, Wechsler SL, Cai S, Nesburn AB, Hofman FM. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology 1998;95:352-9.
20. 20. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992;127:5-24.
21. 21. Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol 1994;68:2118-26.
22. 22. Mosmann TR. Cytokine patterns during the progression to AIDS. Science 1994;265:193-4.
23. 23. Ghiasi H, Cai S, Nesburn AB, Wechsler SL. MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1. Curr Eye Res 1997;16:1152-8.
24. 24. Hendricks RL, Tumpey TM, Finnegan A. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice. J Immunol 1992;149:3023-8.
25. 25. Chun S, Daheshia M, Kuklin NA, Rouse BT. Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes. J Virol 1998;72:5545-51.
26. 26. Dawson CR, Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol 1976;21:121-35.
27. 27. Whitcher JP, Dawson CR, Hoshiwara I, et al. Herpes simplex keratitis in a developing country. Natural history and treatment of epithelial ulcers in Tunisia. Arch Ophthalmol 1976;94:587-92.
28. 28. Kuhn R, Rajewsky K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991;254:707-10.
29. 29. Kohl S, Cox PA, Loo LS. Defective production of antibody to herpes simplex virus in neonates: defective production of T helper lymphokine and induction of suppression. J Infect Dis 1987;155:1179-87.
30. 30. Fischer JE, Johnson JE, Kuli-Zade RK, et al. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol 1997;71:8672-7.
31. + TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J Exp Med 1995;182:1505-15.
32. 32. Moran TM, Isobe H, Fernandez-Sesma A, Schulman JL. Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J Virol 1996;70: 5230-5.
33. 33. Reddehase MJ, Mutter W, Koszinowski UH. In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection. J Exp Med 1987;165:650-6.
34. 34. Kohl S, Loo LS, Drath DB, Cox P. Imerleukin-2 protects neonatal mice from lethal herpes simplex virus infection: a macrophage-mediated, gamma interferon-induced mechanism. J Infect Dis 1989;159:239-47.
35. 35. Sykes M, Romick ML, Sachs DH. Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells. Proc Natl Acad Sci USA 1990;87:5633-7.
36. 36. Sharma DP, Ramsay AJ, Maguire DJ, Rolph MS, Ramshaw IA. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol 1996;70:7103-7.
37. 37. Ikemoto K, Pollard RB, Fukumoto T, Morimatsu M, Suzuki F. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J Immunol 1995;155:1326-33.
38. 38. Leal LM, Moss DW, Kuhn R, Muller W, Liew FY. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur J Immunol 1993;23:566-9.
39. 39. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 1990;171:115-27.
40. 40. Popko B, Corbin JG, Baerwald KD, Dupree J, Garcia AM. The effects of interferon-gamma on the central nervous system. Mol Neurobiol 1997; 14:19-35.
41. 41. Geiger K, Howes EL, Sarvetnick N. Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections. J Virol 1994;68:5556-67.